4.8 Article

The microbiota regulates type 2 immunity through RORγt+ T cells

Journal

SCIENCE
Volume 349, Issue 6251, Pages 989-993

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aac4263

Keywords

-

Funding

  1. Institut Pasteur
  2. Agence Nationale de la Recherche (ANR) [11 BSV3 020 01]
  3. Fondation de la Recherche Medicale [DEq. 2010318246]
  4. Fondation Simone e Cino Del Duca from Institut de France
  5. European Commission [MEXT-CT-2006-042374]
  6. French government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]
  7. European Molecular Biology Organization
  8. European Union
  9. Japan Society for the Promotion of Science [15K19129]
  10. Boehringer Ingelheim
  11. Grants-in-Aid for Scientific Research [15J09641, 15K19129] Funding Source: KAKEN

Ask authors/readers for more resources

Changes to the symbiotic microbiota early in life, or the absence of it, can lead to exacerbated type 2 immunity and allergic inflammations. Although it is unclear how the microbiota regulates type 2 immunity, it is a strong inducer of proinflammatory T helper 17 (T(H)17) cells and regulatory T cells (T-regs) in the intestine. Here, we report that microbiota-induced T-regs express the nuclear hormone receptor ROR gamma t and differentiate along a pathway that also leads to T(H)17 cells. In the absence of ROR gamma t+ T-regs, T(H)2-driven defense against helminths is more efficient, whereas T(H)2-associated pathology is exacerbated. Thus, the microbiota regulates type 2 responses through the induction of type 3 ROR gamma t+ T-regs and T(H)17 cells and acts as a key factor in balancing immune responses at mucosal surfaces.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available